Company / Working Capital per Share
Vir Biotechnology, Inc. Working Capital per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$3.08
FY2025
5-year range
$3.08 / $15.31
FY2021-FY2025
Trend
-55.1%
vs FY2024
Sector context
#140 of 210
Health Care
What the data says
At $3.08, Vir Biotechnology, Inc.'s working capital per share ranks #140 of 210 in the Health Care sector. Working Capital per Share has declined for 3 consecutive years, from $15.31 in FY2022 to $3.08 in FY2025.
Based on SEC 10-K filings.
3.08 in FY2025 with a 5-year CAGR of -13.2%.
Declined from $10.60 to $3.08 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -41.4%
- 5-Year CAGR
- -13.2%
- 10-Year CAGR
- -
Sector benchmark
#140 of 210 in Health CareTop 67% of 210This company $3.08 Sector average $146.86
▼
-97.9% below sector average
Key checks
Key Insights
- Vir Biotechnology, Inc.'s working capital per share has declined for 3 consecutive years.
- In FY2025, working capital per share decreased 55.1% year-over-year.
- Ranks #140 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.08 | -55.1% |
| FY2024 | $6.85 | -35.4% |
| FY2023 | $10.60 | -30.7% |
| FY2022 | $15.31 | +59.7% |
| FY2021 | $9.59 | +53.3% |
| FY2020 | $6.25 | -83.9% |
| FY2019 | $38.81 | +282.0% |
| FY2018 | $10.16 | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026